Acadia Healthcare Company: Will The Acquisition of New Opioid Treatment Clinics Amid Rising Demand Catalyze The Top-Line Growth! 

Acadia Healthcare reported its third quarter earnings for 2024, showcasing notable advancements and facing some challenges. The company delivered a revenue of $816 million, marking an 8.7% increase compared to the same period in the previous year. This growth was attributed to improvements in both patient day rates and the number of patient days. Acadia’s adjusted EBITDA also rose by 10.5%, reflecting solid operational leverage and efficient management amidst rising labor costs, which have shown a favorable trend due to effective recruitment, retention, and engagement strategies.